{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699994686095360.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1001/archsurg.2011.129"}},{"identifier":{"@type":"URI","@value":"http://jamanetwork.com/journals/jamasurgery/fullarticle/407542"}}],"dc:title":[{"@value":"Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699994686095360","@type":"Researcher","foaf:name":[{"@value":"Jeffrey A. Norton"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00040010"}],"prism:publicationName":[{"@value":"Archives of Surgery"}],"dc:publisher":[{"@value":"American Medical Association (AMA)"}],"prism:publicationDate":"2011-06-01","prism:volume":"146","prism:number":"6","prism:startingPage":"724"},"reviewed":"false","url":[{"@id":"http://jamanetwork.com/journals/jamasurgery/fullarticle/407542"}],"createdAt":"2011-06-20","modifiedAt":"2016-12-15","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680523526016","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pancreatic neuroendocrine tumors"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1001/archsurg.2011.129"},{"@type":"CROSSREF","@value":"10.5582/irdr.2017.01007_references_DOI_UkdQz113muO3NIIelMMpBvmRF16"}]}